Seagen is a global biotechnology company dedicated to revolutionizing cancer care. We’re developing transformative therapies that make a meaningful difference in people’s lives.
As a pioneer in antibody-drug conjugates (ADCs), Seagen has led the way in novel cancer therapeutics for more than 20 years. We’re committed to discovering safe and effective solutions to challenging clinical needs. Today, our research efforts are dedicated to advancing a pipeline of innovative therapies for solid tumours and blood-related cancers.
Seagen Denmark ApS
Agern Allé 24
2970 Hørsholm
Denmark
Telephone: +45 78740390
Email: OfficeDK@seagen.com
Registration number: 40738576
CRV number: 40738576
For medical information contact
(+45) 89 88 83 53
medinfoEU@seagen.com